All News

The antiviral drug remdesivir has been shown by researchers to effectively stop the replication mechanism of SARS-CoV-2 that causes COVID-19, according to a new study.

Today, we’re thanking Jessica Tackett, PharmD, BCPS, and Brittany Bissell, PharmD, PhD, BCCCP, both of whom work in the University of Kentucky (UK) HealthCare system.

Pharmacy managers must be clear on, and effectively communicate state law and company policy.

Patients with lupus are experiencing difficulties in accessing medications hydroxychloroquine and chloroquine, 2 medications currently being investigated as potential treatment for the coronavirus 2019 disease.

The objective of the study was to evaluate the association between birth by cesarean delivery with the offspring's risks of obesity and type 2 diabetes in adulthood.

A new study investigated the molecular impact of the cancer-killing PARP-1 inhibitor (PARPi) binding to PARP-1 and found that the drug can be structurally modified to increase its power to kill tumor cells.

Parata Systems has launched the Pharmacy Employee Relief Fund with an initial commitment of $100,000 to support employees of retail, long-term care, hospital, and direct-to-home pharmacies across the United States affected by the coronavirus disease 2019.

The widely available anti-parasitic drug ivermectin is capable of killing COVID-19 within 48 hours in a cell culture, according to a new study.

Although vitamin D helps the body absorb minerals essential for bone health, previous studies have found conflicting evidence on whether low vitamin D levels actually increase the risk of osteoporotic fractures and whether vitamin D supplements can reduce the risk.

The results of this study resonate other results, suggesting that 3D mammograms are more accurate than 2D mammograms and may help 3D mammography become part of routine breast cancer screening.

Additionally, blood group O has a significantly lower risk for the infection compared with non-O blood groups, according to the researchers.

Vaccine skepticism, or a hesitancy or unwillingness to get vaccinated or to vaccinate one’s children, may be the result of some people overestimating the likelihood of negative events.

Public policies to increase compliance with community mitigation strategies may be effective in decreasing community mobility.

Today we’re thanking Andrea and Ann-Marie Idusuyi, 2 sisters working hard on the frontlines of the COVID-19 pandemic.

Remdesivir is not yet licensed or approved anywhere internationally and has not been demonstrated to be safe or effective for the treatment of COVID-19.

Researchers investigated the presence of coronaviruses in the bat population due to an understanding that coronaviruses can spread following a spillover from animals.

Chloroquine, hydroxychloroquine, and azithromycin are currently being evaluated as potential treatments for COVID-19, despite limited evidence to support the drugs’ efficacy.

A new study reports valuable new grip strength metrics that provide health care practitioners with an easy-to-perform, time-efficient screening tool for type 2 diabetes.

The American Lung Association (ALA) has started a $25M initiative to address the coronavirus disease 2019 (COVID-19) pandemic and other future respiratory virus pandemics.

The findings showed that non-SCD congenital anemia diagnosis was associated with a higher risk of HIV acquisition compared with SCD, according to the study authors.

A study based in Brazil has been halted early for safety reasons after patients with coronavirus disease 2019 taking a higher dose of chloroquine developed irregular heart rates that increased their risk of a potentially fatal heart arrhythmia.

Approximately 1 in 40 postmenopausal women diagnosed with breast cancer before the age of 65 had a mutation linked to cancer in the BRCA1 or BRCA2 gene, according to an analysis of data from the Women’s Health Initiative (WHI).

The kinase inhibitor selumetinib was approved for the treatment of pediatric patients aged 2 years and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas.

A new test developed for the coronavirus disease 2019 (COVID-19) that uses saliva has been approved by the FDA, according to Rutgers University.

Today we’re celebrating Seth Heldenbrand, PharmD, dean of experiential education at the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy.

Providers with access to COVID-19 tests have reported false-negative results for some patients, raising concerns about the limitations of tests as a source of reliable information.

Why is spironolactone prescribed by a dermatologist for a young woman with no indications of edema?

Pain is the most common reason patients seek medical marijuana, yet patients' resulting consumption patterns of marijuana when treating pain may also have an effect on their health.

There have been reports of patients with COVID-19 having ST-segment elevation (STE) and, even after invasive coronary angiography, continuing to show no signs of COVID-19.

Although chloroquine and hydroxychloroquine have been touted as potential treatments for COVID-19, physicians in Italy have warned that the global supply may not be able to keep up with demand.